Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US9757388B2 · kind B2 · utility
2Cited by
84References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2012 |
| Grant date | Sep 12, 2017 |
| Priority date | — |
| Expiry date | Nov 26, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.